Since the publication of Katsanos et al’s meta-analysis in the Journal of the American Heart Association (JAHA), the science and support for paclitaxel-releasing devices in the legs is an unfolding story.

A CX 2019 Highlight session will feature two hours of independent review of the data and in-depth debate and discussion.

CX 2019 will challenge the evidence to provide the last word on whether paclitaxel-coated devices are beneficial or detrimental to patients.

Click here to register now.